Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

Japan drug delivery devices market to touch $3.4bn by 2023

Japan’s drug delivery devices market, which was pegged at $2.56bn in 2016, is estimated to reach $3.4bn by 2023, says GlobalData, a recognized leader in providing business information and analytics. According to its latest report, the market is set to experience a CAGR of 4.2% during the forecast period. The report highlights the present conditions […]
Read more

Sepsis & septic shock market to be worth $5.9 billion by 2026

The sepsis and septic shock space across the seven major pharmaceutical markets (7MM) of the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan is set to grow from $2.8 billion in 2016 to $5.9 billion by 2026, representing a compound annual growth rate (CAGR) of 7.9%, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Brexit woes for UK mortgage market as lending slows, says GlobalData

An analysis of the UK mortgage market by GlobalData, a recognized leader in providing business information and analytics, has confirmed that the market started to show signs of slowing down in 2016. Faced by the headwinds of Brexit and a slowing economy, GlobalData’s Global Retail Banking Analytics tool has revealed that while gross advances in H1 2016 were £22bn higher than during the same period in 2015, lending in H2 was flat year-on-year.
Read more

Type 2 diabetes market to more than double, to $64 billion by 2026

The type 2 diabetes space across the seven major markets of the US, France, Germany, Italy, Spain, the UK, and Japan, is set to more than double in value from $26.8 billion in 2016 to around $64 billion by 2026. While the global T2D market is crowded with inexpensive generics and marked by a late-stage pipeline filled with me-too drugs, the market is expected to grow at a strong compound annual growth rate of 8.4%, according to research and consulting firm GlobalData.
Read more

Retail finance to be fast tracked by S40m ZipMoney Investment

According to GlobalData, a recognized leader in providing business information and analytics, Westpac’s A$40m investment in ZipMoney could change the entire retail finance market in Australia. The deal heralds a step change in the provision of retail credit in Australia which will effectively provide consumers with a revolving line of unsecured credit at the point […]
Read more

Artificial Intelligence (AI) is more important to IoT than Big Data insights, says GlobalData

For enterprise software, operational efficiency trumps superfluous features. When it comes to optimising these applications, however, particularly for the Internet of Things (IoT), enterprises need to focus their efforts on the basics of business optimization rather than insight driven innovation. A recent GlobalData survey of 1,000 IoT professionals revealed a heavy reliance on traditional business […]
Read more

Global HER2-positive breast cancer market to face challenges from biosimilars through to 2025

The human epidermal growth factor receptor type 2 (HER2)-positive breast cancer space across the eight major markets of the US, France, Germany, Italy, Spain, the UK, Japan, and China, which is set to hit $9.89 billion in 2025, is likely to face barriers due to the introduction of new biosimilars, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Nephrology and Urology Devices market growth predictions drive $57 billion investment

The latest report on the Nephrology and Urology Devices market from GlobalData, a recognized leader in providing business information and analytics, has highlighted how an explosion in diabetes and hypertension combined with aging populations is driving investment to meet patient needs. Leading companies in this field, principally from Europe and North America, have invested over $42 billion in mergers and acquisitions and nearly $15 billion in capital raisings over the last 3 years.
Read more
1 … 54 55 56 57 58 … 61